Elevated FFA and Skeletal Muscle Lipid Content
Effects of Acute Elevation of Circulating Fatty Acids on Skeletal Muscle Lipid Accumulation and Metabolism in Healthy Lean Young Men
1 other identifier
interventional
12
1 country
1
Brief Summary
There is increasing evidence that skeletal muscle lipid content (IntraMyoCellular Lipid, IMCL) markedly increases the risk of metabolic complications, including insulin resistance and cardiovascular events. The investigator hypothesizes that skeletal muscle is passively taking up FFAs when the availability is high, thereby leading to an increased storage. To test this hypothesis, the investigator wants to manipulate FFA levels, by means of exercise, and monitor intramuscular lipid content. Therefore the objective is to examine the effect of an exercise-induced elevation of FFA on skeletal muscle lipid content in healthy lean men. To this end, skeletal muscle lipid content will be investigated at baseline and after an exercise protocol and again after a four-hour recovery period from exercise, once in a condition with high FFA concentration, once with low FFA concentration. To achieve high- versus low FFA concentrations, an exercise protocol was chosen and participants had to perform this protocol once with a glucose supplementation and once without. Skeletal muscle lipid content will be determined before, directly after exercise and 4 h post exercise (from muscle biopsies) with or without glucose supplementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes
Started May 2013
Shorter than P25 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 16, 2013
CompletedFirst Posted
Study publicly available on registry
July 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedMay 28, 2015
May 1, 2015
3 months
July 16, 2013
May 27, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in IntraMyoCellularLipid (IMCL)content
A muscle biopsy will be withdrawn before, after 2 hours of exercise and again 4 hours post-exercise for later analysis of IMCL.
Baseline, directly postexercise and 4 hours post-exercise
Secondary Outcomes (1)
Change in substrate metabolism
Measured several time points during the test day
Study Arms (2)
Exercise & Glucose
EXPERIMENTAL2 hour exercise while getting glucose-supplementation
Exercise & Fasted
EXPERIMENTAL2 hour exercise while staying fasted
Interventions
Eligibility Criteria
You may qualify if:
- Male sex
- Age 18-30 years
- Lean, BMI 18-25 kg/m2
- Healthy
- Stable dietary habits
- No medication use
You may not qualify if:
- Female sex
- Engagement in programmed exercise \> 2 hours total per week
- Cardiac problems, such as angina pectoris, cardiac infarction and arrhythmias
- First degree relatives with type 2 diabetes mellitus
- Any medical condition requiring treatment and/or medication use
- Unstable body weight (weight gain or loss \> 3 kg in the past three months)
- Participation in other biomedical study within 1 month prior to the screening visit
- Subjetcs, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed, cannot participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Human Biology, Maastricht University Medical Center (MUMC)
Maastricht, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
July 16, 2013
First Posted
July 24, 2013
Study Start
May 1, 2013
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
May 28, 2015
Record last verified: 2015-05